Figure 1. Considerations for effective CAR modified T cell Immunotherapy.
Successful application of CAR modified T cell immunotherapy requires the consideration of several qualities, including the CAR design, tumor microenvironment, patient clinical status, and funding mechanisms required for CAR development and clinical trials.